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ABSTRACT: 
Resveratrol has gained tremendous interest owing to multiple reported health-
beneficial effects. However, the underlying key mechanism of action of resveratrol 
remained largely controversial. Here, we demonstrate that under physiologically 
relevant conditions major biological effects of resveratrol can be attributed to the 
generation of oxidation products such as reactive oxygen species (ROS). At low 
hormetic concentrations (< 50 µM), treatment with resveratrol increased cell viability 
in a set of representative cell models, whereas application of quenchers of ROS 
completely truncated these beneficial effects. Notably, application of resveratrol led 
to mild, Nrf2-specific cellular gene expression reprogramming. For example, in 
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primary human epidermal keratinocytes this resulted in a 1.3-fold increase of 
endogenous metabolites such as glutathione (GSH) and subsequently in a quantitative 
reduction of the cellular redox environment by 2.61 mV mmol GSH per g protein. 
After external application of oxidative stress by using 0.8% (v/v) ethanol, endogenous 
generation of ROS was consequently reduced by 24% in resveratrol pre-treated cells. 
In contrast to the common perception that resveratrol acts mainly as a chemical 
antioxidant or as a target protein-specific ligand, we propose that effects from 
resveratrol treatment are essentially based on oxidative triggering of cells. In relevant 
physiological microenvironments this effect can lead to hormetic shifting of cellular 
defence towards a more reductive state to improve resilience to oxidative stress in a 
manner that can be exactly defined by the redox-environment of the cell.  
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INTRODUCTION  
Polyphenols represent a large collection of natural products featuring health-
beneficial effects 
1
. Resveratrol (3,5,4'-trihydroxy-trans-stilbene, RSV), an 
antimicrobial phytoalexin originally found in white hellebore (Veratrum grandiflorum 
O Loes) and later in red grapes and other plants, is one of the most prominent 
polyphenols. Early studies indicated cancer chemo-preventive properties of RSV 
2
. 
Over the last 15 years, numerous studies claimed additional benefits including cardio-
protective and anti-aging effects 
3
. Consequently, a number of products based on RSV 
have been developed for dietary and dermatological application 
4,5
. Nevertheless, the 
efficiencies of RSV treatments and underlying mechanisms of action remained largely 
controversial. For example, RSV had been suggested to modulate estrogen receptor 
activity 
6
, or act as a caloric mimetic by directly increasing the enzymatic activity of 
the histone deacetylase sirtuin 1 (SIRT1) 
7
. Recently, it was shown that inhibition of 
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phosphodiesterase 4 (PDE4) by RSV increased intracellular amounts of the hunger 
signalling molecule cAMP 
8
. Notably, the reported interaction of RSV with these and 
further target proteins were in many cases low and unspecific (mostly in the mid 
micromolar range). In general, most of these studies assumed a proportional dose-
response relationship of compounds, i.e. a conventional pharmacological (linear) 
threshold model 
9
.  
However, in contrast to the standard pharmacological model, hundreds of studies 
reported (unconsciously) beneficial effects of RSV at “low” but detrimental outcomes 
at “high” doses. Nevertheless, this potentially counterintuitive bi-phasic property of 
RSV was widely ignored 
10
. The large body of these data would hint to hormesis, a 
dose-response relationship that is characterized by low-dose stimulation and high-
dose inhibition, consistent with the Arndt-Schulz law, Hueppe’s rule and other terms 
describing a beneficial stimulation (of poisons) at low doses 
11,12
. General acceptance 
of the hormesis concept for therapeutic application seems to remain low, due to the 
generally low stimulatory effects and particularly due to an often lacking mechanistic 
explanation of the underlying mode of action of so-called hormetic compounds. 
Interestingly, polyphenols including RSV are considered as antioxidants. But 
depending on the chemical context RSV and other polyphenols can also become pro-
oxidative 
1
, a fact that is nevertheless often ignored. Depending on the reaction 
conditions resveratrol can be (auto-) oxidized to generate semiquinones and the 
relatively stable 4'-phenoxyl radical, which can produce reactive oxygen species 
(ROS) 
13,14
. (Auto-) oxidative reactions of polyphenols are influenced by changing 
pH, particularly the presence of hydroxyl anions or organic bases 
15,16
. Additionally, 
metal ions (e.g. iron II ions) facilitate oxidative reactions and further radical 
generation via Fenton reactions 
17
.  
This study aimed to connect fragmented pieces of the chemical and resulting 
biological properties of RSV to provide a conceptually comprehensive mechanistic 
understanding of the varying purported health-beneficial effects of RSV. 
 
MATERIAL AND METHODS 
Materials 
Chemical compounds were purchased from the following sources: 3,5,4'-trihydroxy-
trans-stilbene (resveratrol, RSV) and 4-hydroxy-2-nonenal (HNE) from Cayman 
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Chemical (Biomol, Hamburg, Germany). Reduced glutathione (GSH) was purchased 
from Sigma Aldrich (Taufkirchen, Germany). The composition of Berlin tap water 
can be retrieved from: http://www.bwb.de 
 
Cell culture 
Neonatal normal human epidermal keratinocyte cells (NHEK, CC-2503, Lonza, 
Basel, Swiss) were isolated from a black, newborn male. NHEK cells were 
maintained in keratinocyte growth medium (KGM) containing keratinocyte basal 
medium (KBM, CC-3101, Lonza) and KGM SingleQuot Kit Suppl. & Growth 
Factors (CC-4131, Lonza). Cells were treated with indicated compounds, vehicle 
controls were as follows: DMSO for RSV and EtOH for HNE. GSH was dissolved in 
cell culture medium. Notably, hydrogen peroxide applied in low micromolar 
concentrations (comparable to HNE) did not produce any significant oxidative effects, 
probably due to efficient scavenging in the cellular context.  
Neonatal normal human dermal fibroblast cells (NHDF, CC-209, Lonza) were 
isolated from a Caucasian, newborn male. NHDF cells were maintained in Dulbecco`s 
modified Eagle medium (# 31966, Gibco, Life Technologies, Darmstadt, Germany) 
supplemented with 10% fetal bovine serum (FBS) Medium was renewed every two to 
three days and cells were split two times per week. Cells were treated at 60% 
confluence with 50 µM RSV or vehicle control.  
Human HT-29 colon cells (ACC-299, DSMZ, Braunschweig, Germany) were 
cultured in Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12, 
# 11330-057, Gibco, Life Technologies) supplemented with 5% FBS and 100 U/ml 
penicillin and 100 µg/ml streptomycin (all Biochrom, Berlin, Germany). Human 
THP-1 monocyte cells (ATCC, LGC Standards GmbH, Wesel, Germany) were 
cultivated in RPMI 1640 (Biochrom) supplemented with 10% FBS and 100 U/ml 
penicillin and 100 µg/ml streptomycin.  
Human HepG2 liver cells (ATCC, LGC Standards GmbH), human embryonic kidney 
(HEK293T) cells (ATCC, LGC Standards GmbH) and human HeLa cells (ATCC, 
LGC Standards GmbH) were cultured in DMEM (# 31966, Gibco, Life Technologies) 
supplemented with 10% FBS and 100 U/ml penicillin and 100 µg/ml streptomycin. 
Cells were seeded into 12-well plates (# 3513, Corning, Fisher Scientific, Schwerte, 
Germany) and treated with RSV or vehicle control.  
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Human adult low calcium high temperature keratinocyte cells (HaCaT) and ARE 
clone 7 HaCaT cells were kindly provided by Unilever (Sharnbrook, U.K.). ARE 
clone 7 HaCaT cells were revived in DMEM (# 31966, Gibco, Life Technologies) 
supplemented with 10% FBS. The next day, culture medium was changed to selective 
medium (DMEM with 10% FBS and 400 µg/ml Hygromicin B (# 10687-010, Life 
Technologies)) for continued growth. HaCaT cells were cultured in DMEM (# 21068-
028, Life Technologies) supplemented with 1% FBS, 2 mM L-glutamine (Biochrom), 
1 mM sodium pyruvate (# 11360-039, Life Technologies), 70 µM calcium chloride 
(Merck GmbH, Darmstadt, Germany), 100 U/ml penicillin and 100 µg/ml 
streptomycin.  
All cell lines were maintained at 37°C in a humidified 5% CO2 atmosphere and 
treated at 60% confluence. The following passages were used: NHEK cells p 1, 
NHDF cells p 2-5, ARE clone 7 HaCaT cells p 7, HaCaT cells p 47, HT-29 cells p 27, 
HepG2 cells p 9, HEK293T p 23 and Hela were kindly provided by Dr. David 
Meierhofer. 
 
Analysis of resveratrol integrity 
The Fluor-de-Lys SIRT1 Fluorometric Drug Discovery Assay (BML-AK555-0001, 
Enzo Life Sciences, Lörrach, Germany) was used to analyse the integrity of RSV after 
incubation in diverse solvents according to manufacturer’s instructions. Briefly, 
compounds were added to a mixture of NAD
+
 and Fluor-de-Lys (FdL) peptide in 
reaction buffer (RB). Reaction was started by addition of SIRT1 in RB followed by 
30 min incubation at 37°C. Reaction was stopped by addition of NAM and 
DeveloperII solution. After additional incubation for 45 min at 37°C, fluorescence 
was measured (360/460 nm) using the POLARstar Omega (BMG LABTECH, 
Ortenberg, Germany).  
 
Time-dependent decay of resveratrol (cell-free) 
The time-dependent decay of RSV in diverse solvents was analysed using the 
POLARstar Omega (BMG LABTECH) at 37°C. Samples were transferred (100 
µl/well) into a UV-Star 96-well plate (# 655801, Greiner Bio-one, Frickenhausen, 
Germany) for kinetic and spectral measurement (between 220 and 720 nm, Δλ 2 nm). 
Photos of RSV under various conditions (Fig. S1a and b) to document initial decay 
overnight were taken after about 17.5 hours. 
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pH-dependent oxidation of resveratrol (cell-free) 
The time-dependent oxidation of 50 µM RSV in ddH2O with or without 44 mM 
sodium bicarbonate (NaHCO3) was analysed using the POLARstar Omega (BMG 
LABTECH) at 37°C. Samples were transferred (150 µl/well) into a UV-Star 96-well 
plate (# 655801, Greiner Bio-one) for kinetic and spectral measurement (between 230 
and 550 nm, Δλ 2 nm). The pH of each solution was adjusted from 1 to 12 using HCl 
and NaOH solutions. In accordance to Li, et al. 
14
 oxidation products of RSV, a short-
lived hydroxyl radical adduct of RSV (characteristic absorbance maximum: 420 nm) 
and the relatively stable 4’-phenoxyoxyl radical (characteristic absorbance maximum: 
390 nm), were monitored. For data analyses in GraphPad Prism 5.0 signals were 
background-subtracted and normalized to vehicle control. Data were fitted (dashed 
line) using GraphPad Prism 5.0 with a Hill slope of -1 according to equation:  
          
(          )
(    (         ))
 
 
Oxygen partial pressure-dependent oxidation of resveratrol (cell-free) 
96-well plates prepared for the determination of the pH-dependent oxidation of 
resveratrol (see pH-dependent oxidation of RSV) were incubated at 37°C at 
atmospheric oxygen levels (~ 21% O2), slightly reduced oxygen partial pressure (10% 
O2, mimicking conditions in the blood vessels), or highly reduced oxygen levels (1% 
O2, resembling tissue or tumour microenvironment). For experiments with reduced 
oxygen partial pressure, plates were incubated at corresponding oxygen levels using a 
CO2 Incubator Model CB 60 (Binder, Tuttlingen, Germany). For spectral 
measurements plates were quickly analysed (< 2 min) using the POLARstar Omega 
(BMG LABTECH) at 37°C. Afterwards the plates were further incubated at indicated 
conditions. In accordance to Li, et al. 
14
 the oxidation of RSV and subsequent reaction 
products were monitored. For data analyses in GraphPad Prism 5.0 signals were 
background-subtracted and normalized to vehicle control. Data were fitted (dashed 
line) using GraphPad Prism 5.0 with Hill slope = -1 according to equation:  
          
(          )
(    (         ))
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Measurement of ROS (cell-free) 
The CellROX Green dye (C10444, Life Technologies) was used to quantify the 
formation of extracellular ROS. The dye exhibits a high fluorescence response in 
particular to hydroxyl radicals (HO
•
). Upon oxidation by ROS and after binding to 
nucleic acid the probe exhibits green photostable fluorescence. The CellROX Green 
dye is compatible with cell culture medium and requires no cellular processing, hence 
it is applicable for measurement of ROS generation in a cell-free environment. The 
dye was diluted to 10 µM/well in presence of 1 µg/ml lambda DNA (Life 
Technologies) prior to addition of the indicated compounds. Measurement was 
performed in a final volume of 150 µl/well in black 96-well plates (# 655090, Greiner 
Bio-One). The dye was protected against atmospheric oxygen by adding a sealing 
layer of 100 µl/well mineral oil (Luxcel Biosciences). Fluorescence intensity (Ex 
485/30; Em 530/10) was recorded at 37°C for 16 hours using the POLARstar Omega 
(BMG LABTECH). For data analyses in GraphPad Prism 5.0 fluorescence signals 
were background-subtracted and normalized to vehicle control. Finally, signals were 
plotted in GraphPad Prism 5.0 either using a second order neighbour smoothing (4 
neighbours) for kinetic depiction or the area under the curve (AUC) was calculated 
for summed depiction.  
 
 
Quantification of intracellular ROS 
Formation of ROS was quantified using dye 5-(and-6)-chloromethyl-2',7'-
dichlorodihydrofluorescein diacetate (CM-H2DCFDA, Life Technologies) according 
to the manufacturer’s instruction. In detail, NHEK cells were seeded in a 96-well 
plate (TPP, Biochrom) with a density of 10,000 cells/well. The following day, 
adherent cells were washed once with pre-warmed PBS and loaded with 50 µM dye 
diluted in PBS. For successful incorporation and activation of CM-H2DCFDA, cells 
were incubated for 30 minutes at 37°C. Afterwards, free dye was removed by 
washing with pre-warmed PBS. KGM (100 µl/well) was added and cells were once 
more incubated at 37°C for 60 minutes. Compounds were added as indicated and 
fluorescence (Ex 485/30; Em 530/10) was measured for 16 hours of treatment using 
the POLARstar Omega (BMG LABTECH) at 37°C.  
For the quantification of ROS generation in pre-conditioned NHEKs, cells were 
seeded in a 96-well plate (TPP, Biochrom) with a density of 10,000 cells/well and 
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were pre-treated with 50 µM RSV or vehicle for 16 hours. The following day, 
adherent cells were washed once with pre-warmed PBS and loaded with 50 µM dye 
diluted in PBS. For successful incorporation and activation of CM-H2DCFDA, cells 
were incubated for 30 min at 37°C. Afterwards, free dye was removed by washing 
with pre-warmed PBS. KGM (100 µl/well) was added and cells were once more 
incubated at 37°C for 60 min. Putative protection of NHEKs against oxidative stress 
by RSV pre-treatment was tested by adding ethanol (0.781% v/v) or potent thiol-
scavenger HNE 
18
 at indicated concentrations. Fluorescence (Ex 485/30; Em 530/10) 
was measured for 21 hours of treatment using the POLARstar Omega (BMG 
LABTECH) at 37°C. For data analyses in GraphPad Prism 5.0 fluorescence signals 
were background-subtracted and normalized to vehicle control. Finally, signals were 
plotted in GraphPad Prism 5.0 either using a second order neighbour smoothing (4 
neighbours) for kinetic for kinetic depiction or the area under the curve (AUC) was 
calculated for summed depiction. 
 
Analysis of H2O2 generation (cell-free) 
To determine hydrogen peroxide (H2O2) generation the Amplex Red Glucose/Glucose 
Oxidase Assay Kit (A22189, Life Technologies) and the Hydrogen Peroxide Assay 
Kit (K265-200, BioVision, BioCat, Heidelberg, Germany) were used. DMEM 
samples were filtered using Amicon Ultra-0.5 Centrifugal Filter Unit with Ultracel-10 
membrane (UFC501024) or MultiScreen Ultracel-10 Filter Plate 10 kD 
(MAUF01010, both Merck Chemicals). For each experiment a H2O2 standard curve 
was generated. Samples were mixed with provided dye, horseradish peroxidase 
(HRP) and RB. Fluorescence was measured after 10 to 30 minutes incubation at RT 
using the POLARstar Omega (BMG LABTECH).  
 
Analysis of superoxide generation (cell-free) 
The MitoSOX Red Mitochondrial Superoxide Indicator (M36008, Life Technologies) 
was used to quantify the formation of superoxide (O2
• −
). The dye is readily and 
specifically oxidized by superoxide and exhibits red photostable fluorescence after 
binding to nucleic acids. The probe is compatible with cell culture medium and in 
combination with Lamda DNA (Life Technologies) applicable for measurement of 
superoxide generation in a cell-free environment. The dye was diluted to 10 µM/well 
in presence of 200 ng/well lambda DNA (Life Technologies) prior to addition of 
9 
 
indicated compounds. Measurement was performed in a final volume of 150 µl/well 
in black 96-well plates (# 655090, Greiner Bio-One). The dye was protected against 
atmospheric oxygen by adding a sealing layer of 100 µl/well mineral oil (Luxcel 
Biosciences). Fluorescence intensity (Ex 485/30; Em 530/10) was recorded at 37°C 
for 16 hours using the POLARstar Omega (BMG LABTECH). For data analyses in 
GraphPad Prism 5.0 fluorescence signals were background-subtracted and normalized 
to vehicle control. Finally, signals were plotted in GraphPad Prism 5.0 either using a 
second order neighbour smoothing (4 neighbours).  
 
Viability assay 
For determination of cellular viability NHEK cells were seeded in a black 96-well 
plate (# 353219, BD Biosciences, Heidelberg, Germany) with a density of 10,000 
cells/well and a final volume of 200 µl/well. NHDF, HepG2 and THP-1 cells were 
seeded in a black 384-well plate (# 3712, Corning, Fisher Scientific) with a density of 
2,500 cells/well (NHDF) and 5,000 cells/well (HepG2, THP-1), respectively and a 
final volume of 25 µl/well. The following day, medium was renewed and cells were 
treated with the indicated compounds in a final volume of 100 µl/well (NHEK) and 
35 µl/well (NHDF, HepG2, THP-1), respectively. After 16 hours of treatment, cell 
viability was quantified using the CellTiter-Fluor Cell Viability Assay (G6081, 
Promega, Mannheim, Germany). Fluorescence intensity was measured (410/520 nm) 
using the POLARstar Omega (BMG LABTECH). Data were fitted (dashed line) 
using GraphPad Prism 5.0 with variable Hill slope according to equation:  
          
(          )
(    ((         )           ))
 
Fluorescence intensity values were transformed to the relative number of cells. IC50 is 
the concentration required for a 50% inhibition of viability 
 
RNA isolation, reverse transcription and quantitative real-time PCR 
RNeasy Mini Kit (QIAGEN, Hilden, Germany) was used to isolate total RNA 
according to the manufacturer’s instruction. For cell lysis 10 µl/ml β-mercaptoethanol 
was added to RLT buffer. Genomic DNA was digested on a column using the DNase-
Set (QIAGEN). The concentration of extracted RNA was measured using the 
Nanodrop ND-2000 Spectrophotometer (Thermo Fisher Scientific). RNA was 
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reversely transcribed into cDNA applying the High Capacity cDNA Reverse 
Transcription Kit (Life Technologies) with random primers. After an initial 
denaturation at 95°C for 10 min, the cDNA was amplified by 40 cycles of PCR 
(95°C, 15 sec; 60°C, 60 sec). Quantitative PCR was carried out on the ABI Prism 
7900HT Sequence Detection System using the Power SYBR Green PCR Master Mix 
(all Life Technologies). The relative gene expression levels were normalized using β-
actin gene and quantified by the 2
-ΔΔCt
 method 
19
. Primer sequences are summarized 
in Table S5. Data were analysed using GraphPad Prism 5.0. 
 
Knockdown of NRF2 or SIRT1 with small interfering RNA 
NHEK cells were seeded into 6-well plates (Corning) and transfected with 30 nM 
Silencer Pre-designed siRNA Nrf2 (# 16708), Silencer Pre-designed siRNA SIRT1 (# 
136457) or Silencer Select negative control siRNA (# 4390844, all Ambion, Life 
Technologies) using Lipofectamin 2000 transfection reagent (# 11668019, Life 
Technologies). Transfection was carried out in 1 ml for 48 hours in KGM, whereby 
0.5 ml KGM were added after 24 hours. Medium was then renewed and cells were 
treated with 50 µM RSV or vehicle for 16 hours prior to RNA and protein collection. 
Data were analysed using GraphPad Prism 5.0. 
 
 
Genome-wide gene expression analyses 
Genome-wide gene expression analyses were done by ATLAS Biolabs GmbH 
(Berlin, Germany) on HumanHT-12 Expression BeadChips (Illumina, Eindhoven, 
The Netherlands). All basic expression data analyses were carried out using 
GenomeStudio V2011.1 (Illumina). Raw data were background-subtracted and 
normalized using the cubic spline algorithm. Processed data were filtered for 
significant detection (P value ≤ 0.01) and differential expression vs. vehicle treatment 
according to the Illumina t-test error model and were corrected according to the 
Benjamini-Hochberg procedure (P value ≤ 0.05) in the GenomeStudio software. Gene 
expression data were submitted to the Gene Expression Omnibus database 
(GSE72119).  
Gene Set Enrichment Analysis (GSEA) 
20
 of the RSV gene expression profiles was 
performed using the following parameters: 1000 gene set permutations, weighted 
enrichment statistic, and signal-to-noise metric. Microarray data were analysed using 
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the curated C2 KEGG pathways gene sets (version 4.0, 186 gene sets) from the 
Molecular Signature Database (MSigDB) (Table S2). 
 
Cell cycle analyses 
Analyses of cell cycle regulation were performed in NHEK cells treated with the 
indicated compounds for 16 hours. Trypsinised cells were fixed in 70% ethanol (v/v) 
and incubated on ice for 15 minutes. Fixed cells were then resuspendend in propidium 
iodide (PI)/RNase staining solution (# 4087, Cell Signaling Technology, New 
England Biolabs, Frankfurt, Germany), incubated for 15 minutes at RT and stored at -
20°C until use. Finally, cells were measured in the Accuri C6 flow cytometer (BD 
Biosciences). Data analyses were performed using the Watson pragmatic model in 
FlowJo 7.6 (Tree Star).  
 
Phosphatidylserine externalization (Annexin V) assay 
To quantify apoptosis, the externalization of phosphatidylserine 
21
 was determined in 
NHEK cells treated with the indicated compounds for 16 hours by staining with 
annexin-V-FLUOS and propidium iodide using the Annexin-V-FLUOS Staining Kit 
(Roche Diagnostics, Mannheim, Germany) and subsequent flow cytometry (Accuri 
C6, BD Biosciences). Analyses were performed using FlowJo 7.6 (Tree Star). 
 
 
Immunoblotting 
NHEK were lysed in 50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 1% SDS with 
protease inhibitors (Roche Diagnostics) and phosphatase inhibitors (Sigma Aldrich), 
and sonicated (Bandelin electronic, Berlin, Germany). After centrifugation for 10 
minutes at 10,000 g, the supernatants were stored at -80°C until use. Samples were 
denaturated and separated using a NuPAGE Novex 4-12% Bis-Tris gel (Life 
Technologies) and blotted onto Hybond ECL nitrocellulose membranes (GE 
Healthcare, Freiburg, Germany). Membranes were blocked for 1 hour at RT 
according to the manufacturer's protocol and washed in TBS-T (0.1% w/v). Primary 
antibodies against P-Nrf2 (ab76026, Abcam, Cambridge, UK), Nrf2 (sc-13032X, 
Santa Cruz, Heidelberg, Germany), Sirt1 (MAb-063-050, Diagenode, Seraing, 
Belgium), P-Sirt1 (# 2314), CDK 4 (# 2906), cyclin D1 (# 2926), CDK 2 (# 2546), 
cyclin E2 (# 4132), p21 (# 2947), cyclin A2 (# 4656), caspase 7 (# 9492), cleaved 
caspase 7 (# 8438), caspase 9 (# 9502), cleaved caspase 9 (# 7237), PARP (# 9542), 
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cleaved PARP (# 5625, all from Cell Signaling Technology) and b-Actin (sc-47778, 
Santa Cruz) were diluted in TBS-T (0.1% w/v) with milk powder and BSA, 
respectively, according to the manufacturer's protocols. Membranes were shaken at 
4°C overnight, washed 3 times with TBS-T (0.1% w/v) and subsequently incubated 
with anti-rabbit IgG-HRP (sc-2004, Santa Cruz) and anti-mouse IgG-HRP (sc-2005, 
Santa Cruz), respectively, according to the manufacturer's protocols. Detection was 
carried out with Western Lightning ECL solution (Perkin Elmer, Rodgau, Germany). 
Membranes were stripped with Restore Plus Western Blot Stripping Buffer (Thermo 
Scientific, Life Technologies) for 5 to 7 minutes. A densitometric analysis was 
performed with FUSION-SL Advance 4.2 MP System (Peqlab, Erlangen, Germany). 
 
Detection of lipid peroxidation  
Click-iT Lipid Peroxidation Imaging Kit-Alexa Fluor 488 (C10446, Life 
Technologies) was used to determine the development of cellular lipid peroxides. 
Linoleamide alkyne (LAA, alkyne-modified linoleic acid) is incorporated into cellular 
membranes and oxidized upon lipid peroxidation and finally, resulting in proteins 
labelled with an azide-modified Alexa Fluor 488 dye. Increasing fluorescence 
intensities corresponds to enhance lipid peroxidation upon treatment. NHEK cells 
were seeded in 25 cm² cell culture flasks (Corning) and treated with 50 µM RSV or 
vehicle for 16 hours in presence of 50 µM LAA. After trypsinisation, cells were 
washed with PBS and fixed in 3.7% formaldehyde (v/v) for 15 minutes at RT. Cells 
were washed in PBS, permeabilised by use of 0.5% (v/v) Triton X-100 in PBS for 10 
minutes and subsequently blocked by adding 1% BSA (w/v) for 30 minutes (all at 
RT). Remaining BSA was removed by rigorously washing the cells with PBS. 
Pelleted cells were then incubated with 500 µL Click-iT reaction cocktail for 30 
minutes at RT according to the manufacturer’s protocol. The Click reaction was 
stopped by adding 1% (w/v) BSA/PBS. The cells were washed and resuspended with 
PBS. Flow cytometry was performed on the Accuri C6 (BD Biosciences). Data were 
analysed using FlowJo 7.6 (Tree Star) and GraphPad Prism 5.0.  
 
Antioxidant Assay 
The Antioxidant Assay (# 709001, Cayman Chemical) was conducted according to 
the manufacturer’s manual. The assay was miniaturized to a final volume of 60 
µl/well. Samples including 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 
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(Trolox) standards were mixed with metmyoglobin and chromogen. The reaction was 
initiated by adding hydrogen peroxide solution and incubated 5 minutes at RT on a 
shaker. Finally, the absorbance was read at 405 nm with the POLARstar Omega 
(BMG LABTECH). Data were analysed using GraphPad Prism 5.0. 
 
Quenching of resveratrol effects 
NHEK cells were seeded in 150 cm² cell culture flasks (Corning) and treated with 50 
µM RSV, vehicle alone or in combination with indicated concentrations of GSH, 
respectively for 16 h. Trypsinised cells were subjected to quantitative real-time PCR 
and 25 mM GSH measured in the Accuri C6 flow cytometer (BD Biosciences). Data 
were analysed using GraphPad Prism 5.0 and FlowJo 7.6 (Tree Star). 
 
Intracellular glucose quantification 
Intracellular glucose concentration was determined using the PicoProbe Glucose 
Fluorometric Assay Kit (K688-100, Biovision, BioCat). NHEK cells were seeded into 
25 cm² cell culture flasks (Corning, Fisher Scientific) and treated with 50 µM RSV or 
vehicle for 16 h. Samples were processed according to the manufacturer’s instruction 
and deproteinised using the Deproteinising Sample Preparation Kit (K808-200, 
Biovision, BioCat). The assay was miniaturized to 10% of the initial volume and 
conducted in a clear, small-volume 384-well plate (# 784101, Greiner Bio-one). 
Fluorescence (535/585 nm) was measured after 45 min at using the POLARstar 
Omega (BMG LABTECH). Samples were normalized to protein content. Data were 
fitted (dashed line) using linear regression model in GraphPad Prism 5.0. Trolox 
standard curve was used to convert RSV results into Trolox equivalents and data were 
fitted (dashed line) using linear regression model. 
 
Intracellular pyruvate quantification 
Intracellular pyruvate concentration was determined using the Pyruvate Assay Kit (# 
700470, Cayman Chemical). NHEK cells were seeded in 150 cm² cell culture flasks 
(Corning) and treated with 50 µM RSV or vehicle for 16 hours. Sample preparation 
was done according to the manufacturer’s instruction. Fluorescence (530/585 nm) was 
measured after 20 minutes using the POLARstar Omega (BMG LABTECH) at 37°C. 
Samples were normalized to protein content. Data were analysed using GraphPad 
Prism 5.0. 
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Intracellular lactate quantification  
Lactate content was quantified with the Lactate Assay Kit (# 700510, Cayman 
Chemical). NHEK cells were seeded in a 150 cm² (Corning) and treated with 50 µM 
RSV or vehicle for 16 hours. Sample preparation was done according to the 
manufacturer’s instructions. Fluorescence (530/585 nm) was measured using the 
POLARstar Omega (BMG LABTECH) at 37°C. Samples were normalized to protein 
content. Data were analysed using GraphPad Prism 5.0. 
 
Analyses of intracellular ADP and ATP 
The ADP Colorimetric/Fluorometric Assay Kit (K355-100) and ATP 
Colorimetric/Fluorometric Assay Kit (K354-100, both Biovision, BioCat) were used 
to quantify intracellular ADP and ATP content. Briefly, NHEK cells were seeded into 
150 cm
2
 cell culture flasks (Corning) and treated with 50 µM RSV or vehicle for 16 
hours. Flasks were washed once with ice cold PBS prior to harvest using a dispenser 
(TPP). Cell suspensions were centrifuged at 1,000 g for 5 minutes at 4°C and 
resuspended in ice-cold extraction buffer, aliquoted and stored at -20°C until usage. 
The assay was miniaturized to 10% of the initial volume and conducted in a clear, 
small-volume 384-well plate (# 784101, Greiner Bio-one) according to the 
manufacturer’s protocol. Optical density was measured after 45 minutes at 570 nm 
using the POLARstar Omega (BMG LABTECH). Samples were normalized to 
protein content. Data were analysed using GraphPad Prism 5.0. 
 
Intracellular NAD
+
 and NADH quantification 
Intracellular NAD
+
 and NADH content was analysed using the colorimetric 
NAD/NADH Quantitation Kit (Biovision, BioCat) according to the manufacturer’s 
instruction. Briefly, NHEK cells were seeded into 150 cm
2
 cell culture flasks 
(Corning) and treated with 50 µM RSV or vehicle for 16 hours. Flasks were washed 
once with ice cold PBS prior to harvest using a dispenser (TPP). Cell suspensions 
were centrifuged at 1,000 g for 5 minutes at 4°C and resuspended in ice-cold 
extraction buffer. Afterwards, cells were lysed by two freeze-thaw-cycles, followed 
by intensive vortexing and centrifugation at 20,800 g for 15 minutes at 4°C. Part of 
the cell lysate was incubated at 60°C for 30 minutes to generate NAD
+
. Cycling 
buffer, enzyme mix and developer were added according to the manufacturer’s 
15 
 
protocol. Optical density was measured after 30 minutes at 660 nm using the 
POLARstar Omega (BMG LABTECH). Samples were normalized to protein content. 
Data were analysed using GraphPad Prism 5.0. 
 
Analyses of intracellular NADP
+
 and NADPH 
The NADP/NADPH-Glo Assay Kit (G9081, Promega) was used to quantify the 
intracellular NADP
+
 and NADPH content. NHEK cells were seeded into a 12-well 
plate and treated with 50 µM RSV or vehicle for 16 hours. The following day, cells 
were washed once in PBS, 60 µl PBS/well were added and cells were lysed in 60 µl 
base solution with 1% (w/v) dodecyl(trimethyl)azanium bromide (DTAB, D8638, 
Sigma Aldrich). Afterwards, 50 µl lysate were transferred into a clear 96-well plate to 
measure NADP
+
 and NADPH individually according to the manufacturer’s protocol. 
Finally, 30 µl sample were transferred to a white-walled clear-bottom 384-well plate 
(# 781098, Greiner Bio-one) and 30 µl of NADP/NADPH-Glo Detection Reagent 
were added. Luminescence was measured after 30 minutes using the POLARstar 
Omega (BMG LABTECH). Samples were normalized to protein content. Data were 
analysed using GraphPad Prism 5.0. 
 
 
 
Analyses of intracellular reduced and oxidized glutathione 
Intracellular reduced (GSH) and oxidized (GSSG) glutathione were quantified using 
the GSH/GSSG-Glo Assay Kit (V6611, Promega). NHEK cells were seeded in a 96-
well plate (TPP) with a density of 30,000 cells/well. The following day, cells were 
treated with 50 µM RSV or vehicle for 16 hours. The assay was miniaturized to 25% 
of the initial volume and conducted according to the manufacturer’s protocol. In brief, 
cell culture medium was removed, 12.5 µl/well Total Glutathione Lysis Reagent or 
Oxidized Glutathione Lysis Reagent were added and incubated for 5 min at RT while 
shaking. Afterwards, 12.5 µl/well Luciferin Generation Reagent were added and 
incubated at RT for 30 minutes. Samples and standards were transferred to a white 
96-well plate (# 655083, Greiner Bio-one) and 25 µl Luciferin Detection Reagent 
were added. Luminescence was measured after 15 minutes using the POLARstar 
Omega (BMG LABTECH). Samples were normalized to protein content. Data were 
analysed using GraphPad Prism 5.0. 
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Oxygen consumption assay 
Analyses of oxygen consumption was conducted by using the cell impermeable, 
oxygen-sensing fluorophore MitoXpress Xtra (Luxcel Biosciences). NHEK cells were 
seeded in a 96-well plate (TPP, Biochrom) with a density of 25,000 cells/well. The 
day after, cells were treated with 50 µM RSV or vehicle for 16 hours and afterwards 
equilibrated for 20 minutes under CO2-free conditions at 37°C. After aspirating cell 
culture medium, 62.5 nM/well MitoXpress Xtra diluted in KGM (LONZA) was 
added. The plate was incubated for 10 minutes under CO2-free conditions at 37°C. 
Compounds were added as indicated and each well was sealed with 100 µl HS 
Mineral Oil (Luxcel Biosciences). Dual-read time-resolved fluorescence (TR-F) was 
measured (380/650 nm) with the POLARstar Omega (BMG LABTECH) at 37°C. 
Lifetime, dual-delay and gate times were calculated and set according to the 
manufacturer’s instructions. Data were analysed using GraphPad Prism 5.0. 
 
Fluorescence microscopy 
NHEK cells were seeded in X-well tissue culture chambers (Sarstedt, Nürnbrecht, 
Germany) at a density of 20,000 cells/well. One day later, adherent cells were treated 
for 16 hours with the indicated compounds. Visualization of MAP1LC3A, Actin, 
Nrf2, Keap1, GCLC and GSR was done as recently described in Weidner, et al. 
22
. In 
brief, cells were washed with PBS (Sigma Aldrich) and fixed in 4% (v/v) 
formaldehyde/PBS (Sigma Aldrich) for 15 minutes at RT. Cells were washed with 
PBS (Sigma Aldrich), permeabilised in 0.3% (v/v) Triton X-100/PBS (PBS-Tx) for 
10 minutes at RT, washed with PBS and afterwards blocked in 5% (v/v) goat serum 
(Sigma Aldrich) in PBS-Tx for 60 minutes at RT. Afterwards, cells were incubated 
with primary antibodies at 4°C overnight. Primary antibodies and dilutions were as 
follows: MAP1LC3A (1:100; AP1801d-ev-AB, Biovision, BioCat), Nrf2 (1:100; sc-
13032X, Santa Cruz; 1:100), Keap1 (1:100, sc-365626, Santa Cruz), GCLC (1:100, 
ab41463, Abcam) and GSR (1:100, sc-133159, Santa Cruz). Subsequently, cells were 
washed with PBS-Tx and stained with anti-mouse IgG (H+L) F(ab')2 fragment Alexa 
Fluor 555 Conjugate (# 4409, Cell Signaling Technology) and anti-rabbit IgG (H+L), 
F(ab')2 fragment Alexa Fluor 488 Conjugate (# 4412, Cell Signaling Technology) 
diluted (1:1,000) in 1% (w/v) BSA/PBS-Tx for 1 h at RT in the dark. Subsequently, 
cells were washed with PBS for 5 minutes, and the MAP1LC3A stained cells were 
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counterstained with F-actin probe Texas Red-X Phalloidin (1:100, T7471, Life 
Technologies) for 20 minutes at RT in the dark. Cells were washed with PBS, the 
chamber was removed from the slide, samples were counterstained with ProLong 
Gold Antifade Mountant (with DAPI) solution (Life technologies), a cover slip 
applied (# 235503704, Duran Group, Wertheim/Main, Germany) and incubated at RT 
for 24 hours. Fluorescence microscope imaging was performed on the LSM700 
(Zeiss, Jena, Germany). 
 
Redox potential, redox state and redox environment 
To calculate the half-cell reduction potential of a selected redox couple the Nernst 
equation (Eq. 1) was used and transformed to match the experimental conditions (T = 
310K = 37°C, pH 7) (Eq. 2). 
        
  
  
     
Eq. 1 
     
   
      
 
      
Eq. 2 
R is the gas constant (8.314 J K
-1
 mol
-1
), T the temperature in Kelvin, n the number of 
electrons exchanged, F the Faraday constant (9.6485*10
4
 C mol
-1
) and Q the mass 
action expression. As the standard reduction potential (E
0
, E
0’
) is pH dependent, an 
adjustment is necessary:  
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Eq. 3 
EpH represents the half-cell reduction potential at a given pH, while ΔE/ΔpH is 
dependent on the number of electrons and protons involved. Finally, the half-cell 
reduction potential of a selected redox couple can be calculated according to (Eq. 5).  
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Eq. 5 
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The half-cell reduction potential can be calculated for the following metabolites 
(redox couples): 
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Eq. 9 
Finally the redox environment is calculated using the redox couple 2GSH/GSSG 
alone (Figure 5a and Table S4) or redox couples lactate/pyruvate, NADH/NAD
+
 and 
2GSH/GSSG (Fig. S7d and Table S4), respectively.  
To relate the reduced redox environment to a future oxidative challenge, we did a 
thought experiment focusing on oxidation of ethanol to acetaldehyde and 
simultaneous ROS generation 
23-25
: 
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Eq. 10 
In order to estimate the amount of ethanol caused ROS generation, which can be 
quenched by RSV pre-treatment, we made the following assumptions: 
• pH 7,  
• T = 37°C, 
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• 2GSH/GSSG redox couple is the driving force of the redox environment and 
• Concentrations of GSH and GSSG as measured at pH 7.0026 (vehicle) and 
7.0632 (RSV), respectively. 
At equilibrium, change of the half-cell reduction potentials of both couples equal 0 
and can be transformed appropriately: 
                  
Eq. 11 
                             (                          ) 
                                                       
                                           
Eq. 12 
According to Sarkola, et al. (2002) 
26
 the formation of acetaldehyde in humans is 
dependent on the amount of ethanol. The mean slope was determined as follows: 
    
               
          
 
                    
                
 
Eq. 13 
We can use this information to calculate QVehicle:  
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Eq. 14 
Finally we can calculate QRSV accordingly: 
                                           
Eq. 15 
                                           
       
                         
         
             
Eq. 16 
                                                                         
                                           
Eq. 17 
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Thus, we can estimate that owing to RSV pre-treatment and the resulting shift in 
redox environment, NHEKs are likely to tolerate roughly 26% more ethanol than 
vehicle pre-treated cells. Notably, NHEK cells did not tolerate higher doses of ethanol 
without serious reduction of viability. Consequently, experimental evidence for this 
gedankenexperiment can finally not be provided. 
We further challenged RSV pre-treated NHEKs with HNE, a potent thiol scavenger 
18,27,28
. As 1 molecule GSH is needed to detoxify 1 molecule HNE, we can roughly 
estimate the amount of additional HNE quenched by increased cellular concentrations 
of GSH after RSV pre-treatment. While RSV pre-treatment has still a protective effect 
at 15 µM HNE, this protection is abrogated at 25 µM HNE. Corresponding to the 
increased GSH content (7 µmol per g protein, roughly 2 µM) due to pre-treatment 
with RSV, the pre-conditioning effect is depleted at HNE concentrations ≥ 25 µM. 
Nevertheless, this is just an approximation, as the GSH pool regulates the reduction 
state of many biological molecules and because HNE can efficiently react with many 
intracellular thiol groups, lipids and proteins present in the biological system. 
 
Statistical analyses 
Data are expressed as mean ± standard error (s.e.m.), if not otherwise denoted. 
Statistical tests were performed in GraphPad Prism 5.0. For comparison of two groups 
statistical significance was examined by unpaired two-tailed Student’s t-test. One-way 
ANOVA with subsequent Dunnett’s post-test was used for multiple comparisons. A P 
value ≤ 0.05 was defined as statistically significant. 
 
RESULTS AND DISCUSSION 
RSV is unstable under physiologically relevant conditions 
The vast majority of studies seem to assume specific RSV-target protein interactions, 
which implies that RSV remains intact during treatments. However, after incubation 
in various media containing physiological concentrations of sodium bicarbonate 
(NaHCO3), a key component of water as well as buffer of blood and biological cells, 
RSV reacts efficiently, as indicated by striking yellowish colour changes (Fig. S1a 
and b). Light absorbance at characteristic RSV maximum (308 nm) decreased rapidly 
in water and cell culture media, both containing sodium bicarbonate (Fig. S1c and d, 
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Table S1). After 16 hours incubation the absorption maximum of RSV was almost 
completely diminished. Furthermore, using a commonly applied fluorescence-based 
SIRT1 assay no enzymatic activation could be detected (Fig. S1e).  
 
Figure 1: RSV produces ROS and triggers cellular defense. (a and b) Kinetic (a) and summed (b) intracellular 
ROS generation in primary NHEK cells after administration of 50 μM RSV. Values are mean ± s.e.m. (n = 6); 
AUC, area under the curve; RFU, relative fluorescence units. (c) Generation of superoxide in H2O and 
keratinocyte growth medium (KGM) after addition of 50 μM RSV for indicated time periods. Values are mean ± 
s.e.m. (n = 4). (d) RSV (50 μM) induced lipid peroxidation in NHEKs. Values are mean ± s.e.m. (n = 4); *P < 0.05 
versus vehicle. (e) Selection of enriched KEGG pathways in NHEKs treated with 50 μM RSV using gene set 
enrichment analysis (GSEA). Values are normalized enrichment scores (NES, n = 4 for vehicle, n = 3 for RSV); * 
P < 0.05, ** P < 0.01, *** P ≤ 0.001 versus vehicle. See also Table S2. (f) GSH considerably quenched RSV 
effects on gene expression. Values are mean ± s.e.m. (n = 4); ** P < 0.01; *** P ≤ 0.001 one-way ANOVA versus 
RSV. 
 
Oxidation of resveratrol at atmospheric oxygen level (21% O2, as usually applied in 
cell culture) 
16,29
 could potentially be considered as non-physiological (in blood 
vessels the oxygen amount is roughly 14% and in tissues or tumours even lower (~ 
1% O2) 
30
. We showed that the auto-oxidation of RSV is highly dependent on the 
presence of sodium bicarbonate and pH of the solvent 
14,31
 (see Figure 1 and 2 in 
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Reference 
31
), whereas decreasing oxygen partial pressure seems to have a 
comparably minor influence on the oxidation efficiency of RSV (see Figure 3 and 4 in 
reference 
31
). These data suggest that oxidation of RSV can even take place in 
hypoxic microenvironments. 
These results corroborate widely ignored findings that the stability and oxidation of 
RSV in physiologically relevant media is strongly influenced by pH and in particular 
the availability of hydroxyl anions 
16,29,32
. Interestingly, RSV reacted also efficiently 
in tap water (Fig. S2e left), which might explain further the often-reported perplexing 
low bioavailability of RSV in vivo 
33-35
. Although RSV could potentially be protected 
from protein carriers such as serum albumin 
36
, the entirety of these data makes it 
difficult to understand how RSV could exert compound-protein specific effects. These 
results further indicate that potential metabolisation of RSV, for example by oxidation 
of the enzymes of the CYP1 family, might play a minor role in physiological context, 
consistent with the usually extremely low amounts of detected metabolites of 
resveratrol 
33-35
. 
 
RSV produces ROS under physiologically relevant conditions 
We next asked how the oxidising RSV could induce relevant biological effects. 
Notably, treatment of cells with RSV resulted in time- and concentration-dependent 
generation of intracellular ROS (Figure 1a and b, Fig. S2a).  
Owing to the complexity of biological matrices it remains technically impossible to 
detect exactly unstable intermediate ROS. However, using defined solvents or a cell-
free environment, we detected significantly increased amounts of ROS, including 
superoxide (O2
• −
, Figure 1c), hydroxyl radicals (HO
•
, Fig. S2b-d) and hydrogen 
peroxide (Fig. S2e) 
14,16
. For example, between 5.0 and 12.5 µM hydrogen peroxide 
(Fig. S2e) was generated depending on the concentration of RSV and sodium 
bicarbonate (Fig. S2e left), whereas (metabolic) scavengers such as pyruvate strongly 
depleted ROS (Fig. S2e right). As revealed by an antioxidant assay using trolox as 
control compound, in presence of sodium bicarbonate the anti-oxidative feature of 
ROS-producing RSV was strongly diminished (Fig. S2f left). In contrast, RSV 
showed roughly 2-fold higher anti-oxidative capacity in solvents lacking sodium 
bicarbonate (Fig. S2f right). These data suggest that RSV loses in part its anti-
oxidative properties and becomes more pro-oxidative in physiological media 
containing sodium bicarbonate. 
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These data indicate that oxidation of RSV takes place under physiologically relevant 
conditions that differ significantly from experimental setups applied to analyse RSV 
by common bicarbonate-free enzymatic assays, or bicarbonate-free crystallization 
procedures that are mostly used for x-ray analyses. Notably, low concentrations of 
oxidation products of RSV such as ROS can mildly affect cellular biomolecules such 
as proteins and lipids (Figure 1d).  
 
Effects on primary human keratinocytes 
We next asked how oxidation of RSV might influence physiological effects. Given 
the here observed oxidative effects in particular topological application of RSV seems 
a medially relevant approach, as is evident from the number of available 
dermatological products based on RSV. We thus focused in this study on potential 
protection of the human epidermis. Notably, due to ethical considerations and law, for 
physiological testing dermatological research applies ex vivo models such as the here 
used primary human keratinocytes that form the outer layer of the skin. Keratinocytes 
are known to build a tight layer of cells that can be used as epidermal grafts (Fig. S2g) 
37
, and these cells represent a prime target for lotions and emollients based on RSV 
38,39
.  
Firstly, we investigated potential oxidation of cellular components owing to oxidation 
products of RSV. Sixteen hours of treatment with 50 µM RSV slightly elevated lipid 
peroxidation in human primary keratinocyte (NHEK) cells, indicating mildly 
increased oxidation of cellular biomolecules (Figure 1d).  
Moreover, to globally monitor cellular response to oxidation products of RSV, 
genome-wide RNA expression analyses revealed a slight but significantly increased 
expression of molecular pathways covering oxidative stress response and 
inflammatory signalling, as well as fatty acid metabolism (Figure 1e and Table S2). In 
contrast, processes linked to proliferation, DNA replication and cell cycle were down-
regulated. Importantly, quenching of oxidation by adding strong reducing molecules 
such as 25 mM synthetic GSH significantly reversed expression of cell response 
marker genes (Figure 1f). As shown in a control experiment, quenching by synthetic 
GSH in reduced the levels of ROS derived from RSV in cell-free environment (Fig. 
S2h) and even more importantly within cells (Fig. S2i), suggesting that ROS derived 
from RSV mainly cause the observed gene expression effects. As tested with a small 
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panel of unrelated cell models, despite cell-specific defence mechanisms the here 
observed gene expression events seem to some degree be independent from cellular 
background (Fig S3a-d, Table S3).  
These data indicate to our knowledge for the first time that major gene expression 
events induced by RSV can be explicitly attributed to the development of oxidation 
products of RSV such as ROS, since depletion by molecular quenchers strongly 
truncated cellular response. The effects of RSV analysed here in mammalian cells 
might also underlie phytoalexin-based protection of plants against microbial infection 
40
. 
 
Oxidative products of RSV cause hormetic effects  
In a next step, we asked how oxidation products derived from RSV could potentially 
influence viability of cells. Using common cell viability assays, we observed 
increased cellular fitness up to about 50 µM RSV in treated NHEKs, whereas higher 
concentrations tend to produce toxic effects, leading to a typical bi-phasic, hormetic 
dose-viability curve (Figure 2a and b). Notably, in additional cellular models for 
fibroblasts and liver we observed similar bi-phasic dose-viability curves as for NHEK 
cells but (depending on the cell model) varying susceptibility to oxidative products 
derived from RSV treatment (Figure 2c-d). Slight but significantly increased 
expression of molecular markers for oxidative stress response, such as catalase 
(CAT), could be observed up to 100 µM RSV with a maximum at 50 µM RSV 
(Figure 2b). On the other hand, too high concentrations of RSV (> 100 µM RSV) can 
result in toxic effects (Figure 2b). In summary, these data are in line with a large body 
of mostly unconsciously reported hormetic cellular effects of RSV 
10
. 
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Figure 2: Hormetic effects are induced by generation of ROS derived from RSV. (a) RSV decreased viability 
of NHEKs after 16 hours treatment at concentrations ≥ 50 μM (IC50: 223.8 μM). RSV effects on viability are 
considerably quenched by GSH (IC50: 247,747.0 μM). Values are mean ± s.e.m. (n = 3). (b) Dose-response curve 
of RSV in treated NHEKs (blue). Hormetic zone emerges from 1 to 60 μM RSV and highest molecular effects 
(gene expression peaks of oxidative stress response gene catalase (CAT)) were generally observed at 50 μM RSV. 
(c) RSV decreased viability of NHDF cells at concentrations ≥ 300 μM (IC50: 342.5 μM), which was quenched by 
GSH (IC50: 1,163.0 μM). Values are mean ± s.e.m. (n = 6). (d) RSV decreased viability of human HepG2 liver 
cells at concentrations ≥ 150 μM (IC50: 445.3 μM), GSH quenched RSV induced effects. Values are mean ± s.e.m. 
(n = 6). 
 
Importantly, the hormetic dose-viability curve was strongly truncated by adding 25 
mM synthetic GSH as a quencher, providing to our knowledge for the first time 
strong evidence that increased viability of cells after RSV treatment mainly derived 
from ROS and related products of RSV (Figure 2a-d). In other words, the mechanism 
of action of RSV to slightly improve cellular fitness seems to rely significantly on 
oxidative effects of RSV, resulting in a bi-phasic, concentration-dependent cellular 
response. 
Further concentration- and time-dependent treatments of NHEKs resulted in generally 
slight up-regulation of a number of metabolic, aging, oxidative stress and 
inflammation signalling genes (Figure 3a-d and Fig. S3e-h). Notably, in NHEKs these 
cellular responses could be observed in a concentration range of approximately 5 to 
100 µM RSV. Strong changes in gene expression were observed after at least 12 
hours, most efficiently after 16 hours of treatment.  
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Figure 3: Cellular response to RSV-derived oxidation products including ROS is mediated by the redox-
sensitive transcription factor Nrf2. (a, b, c and d) Concentration-dependent effects of RSV in NHEK cells after 
16 hours. Values are mean ± s.e.m. (n = 4); # P < 0.05 versus vehicle. Nrf2 and its target genes are marked in bold 
font. See also Fig. S3a-d. (e) Translocation of Nrf2 and increased amount of nuclear phosphorylated Nrf2 as well 
as nuclear Nrf2 protein. Densitometric analysis of immunoblots relative to vehicle, with all gels run under the 
same experimental conditions and cropped blots depicted (copping: dashed line). Values are mean ± s.e.m. (n = 4), 
** P < 0.01. V, vehicle; R, RSV. (f) Quantification of gene expression after knockdown of Nrf2 in RSV treated 
(16 hours) NHEKs. Values are mean ± s.e.m. (n = 4); * P < 0.05, ** P < 0.01, *** P ≤ 0.001 one-way ANOVA 
versus negative siRNA vehicle. See also Fig. S5a. 
 
The entirety of the above shown data suggests that under physiological relevant 
conditions increased viability of cells after RSV treatment was triggered by ROS (and 
potentially also other radicals of RSV), leading to up-regulation of major cell defence 
genes. Instead of the conventional pharmacological (linear) threshold model we 
observed a bi-phasic mode of action of RSV: at normally applied non-toxic 
concentrations, RSV treatment results in increased cellular fitness based on related 
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molecular events, whereas at higher concentrations RSV treatment results in toxic 
effects. The underlying reason for this cellular behaviour seems to depend largely on 
the pro-oxidative properties of RSV. 
In summary, the here proposed link introduces an explicit explanation of the so far 
rather “nebulous” hormetic effects of RSV.  
 
Hormetic effects of oxidative products derived from RSV are driven by 
activation of Nrf2  
We next asked how oxidising RSV could induce any specific molecular response in a 
cellular context. Especially the nuclear factor (erythroid-derived 2) like 2 (Nrf2) is 
considered responsible for accommodating oxidative stress (Fig. S4a) 
2,41-43
. 
Consistent with the above shown production of oxidation products of RSV, we 
observed translocation of redox-sensitive Nrf2 into the nucleus of NHEKs (Figure 3e 
and Fig. S4b), leading to regulation of known Nrf2 target genes (Figure 3a-d bold 
font). Remarkably, knockdown of mRNA expression of Nrf2 gene by small 
interfering RNAs (siRNAs) significantly decreased the observed effects of RSV on 
gene expression response (Figure 3f and Fig. S5a). This experiment indicates that 
Nrf2 via its well-established canonical signalling model mediates major response of 
NHEKs to the oxidation products of RSV. 
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Figure 4: RSV induced autophagy and G1 phase cell cycle arrest but did not cause apoptosis in NHEK cells. 
(a) Fluorescence staining marking DAPI (blue), microtubule-associated protein 1 light chain 3A (MAP1LC3A, 
green) and Actin (magenta) in RSV treated NHEKs. See also Fig. S5b. (b) G1 phase cell cycle arrest in NHEKs 
after 16 hours of treatment with 50 μM RSV . Values are mean ± s.e.m. (n = 4); * P < 0.05; ** P < 0.01, *** P ≤ 
0.001 versus vehicle. See also Fig. S5c. (c) RSV substantially increased the ratio of caspase 7 and PARP 
suggesting slight apoptosis. All gels were run under the same experimental conditions and cropped blots depicted 
(copping: dashed line). Values are mean ± s.e.m. (n = 4); * P < 0.05, ** P < 0.01, *** P ≤ 0.001 versus vehicle. 
(d) None of the tested RSV concentrations did induce apoptosis after 16 hours of treatment of NHEKs, but 150 μM 
RSV tend to increase necrotic cell proportion. Values are mean ± s.e.m. (n = 2). See also Fig. S5e. 
 
ROS and further radicals can produce numerous effects as a result of increased 
oxidation of cellular biomolecules, leading for example to inhibition of protein 
activity. Thus, we would expect multiple cellular defence mechanisms to counteract 
ROS including for example autophagy and cell cycle arrest. Interestingly, RSV 
treatment slightly increased autophagy, probably to degrade and recycle potentially 
damaged cellular components (Figure 4a and Fig. S5b), corroborating previous 
observations 
44
. Simultaneously, primary NHEKs were arrested in G1 cycle phase 
(Figure 4b and Fig. S5c). Interestingly, the cells did not show any signs of senescence 
or apoptosis (Figure 4c and d, Fig. S5d and e) and revealed reduced necrosis (Figure 
4d).  
In the context of increasing autophagy and overall molecular stress, this mechanism 
might allow cells to focus their limited resources on cellular repair, while decreasing 
cellular proliferation and nucleotide synthesis (Figure 1e). Notably, similar effects 
were observed for mild stress such as calorie restriction to improve cellular fitness 
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45,46
. Evidently, many of the effects described appear to be specifically mediated via 
activation of the redox-sensitive transcription factor Nrf2. We next asked if and how 
other reported factors such as the promiscuously reacting deacetylase SIRT1 could 
potentially modulate the effects derived from RSV-based activation of Nrf2, for 
example in the context of autophagy.  
As shown above, under physiologically relevant conditions the almost completely 
degraded RSV can merely directly or allosterically induce the enzymatic activity of 
SIRT1 (Fig. S1e). However, the 4-fold up-regulation of SIRT1 expression (Figure 
3b), the phosphorylated SIRT1 (Fig. S6a) and the simultaneously increased 
NAD
+
/NADH ratio (Figure 5a and Fig. S7d) might contribute to modify the mild 
effects derived from oxidized RSV. Knockdown of SIRT1 gene resulted in 20% lower 
expression of NRF2, suggesting a potential modifying effect of the lysine deacetylase 
SIRT1 on Nrf2 (Fig. S6b). However, at least in NHEKs – in contrast to knockdown of 
NRF2 – knockdown of SIRT1 did not strongly influence overall gene or protein 
expression (Fig. S6c and d), corroborating the major role of Nrf2 in the response to 
oxidative products such as ROS derived from RSV. 
Oxidative products of RSV induce a reduced cellular redox environment 
We then asked how gene expression mediated by RSV/ROS-based activation of Nrf2 
might influence cellular metabolism. In NHEKs treated for 16 hours with 50 µM 
RSV, we observed phosphorylation signalling events such as increased 
phosphorylation of pyruvate dehydrogenase E1 component subunit alpha (PDE1) at 
serine 293 (Fig. S7a), an effect known to inhibit endogenous pyruvate breakdown and 
oxidative phosphorylation 
47
. Consequently, this molecular effect led to increased 
intracellular levels of the potential ROS-scavenger pyruvate while lactate remained at 
constant levels (Figure 5a). Under constant mitochondrial biogenesis (Fig. S7b), we 
further observed decreased mitochondrial oxygen consumption during 16 hours of 
RSV treatment (Fig. S7c).  
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Figure 5: RSV influenced the concentration of key metabolites to shift the cellular redox environment to a 
reduced state, thereby increasing robustness versus oxidative stress. (a) Shift in intracellular metabolite 
concentrations after treatment with 50 μM RSV for 16 hours in NHEKs. Values are mean ± s.e.m. (NADH, NAD+ 
n = 3; glucose, ATP, ADP, GSH, GSSG n = 4; lactate, pyruvate, NADPH, NADP+ n = 5); * P < 0.05, ** P < 0.01; 
*** P ≤ 0.001 versus vehicle. See also Fig. S7d. (b) RSV substantially induced gene expression of glutathione 
metabolism marker genes. Values are mean ± s.e.m. (n = 4); *** P ≤ 0.001 versus vehicle. (c) GSH/GSSG ratio 
was used to calculate the redox environment. See also Table S4 and for calculation with various metabolites Fig. 
S7f. (d) Pretreatment of NHEKs with 50 μM RSV for 16 hours decreased intracellular ROS generation after 
subsequent treatment with ethanol (0.78 %), while increasing concentrations of thiol/GSH-scavenger HNE revised 
ROS-protective potential. Values are mean ± s.e.m. (n = 7); ** P < 0.01, *** P ≤ 0.001 versus vehicle. AUC, area 
under the curve; RFU, relative fluorescence units. 
 
Moreover, the intracellular ratio of metabolite couples 2GSH/GSSG and ATP/ADP as 
well as the amount of glucose significantly increased (Figure 5a and Fig. S7d). In 
contrast the intracellular ratios of metabolite couples NADH/NAD
+
 and 
NADPH/NADP
+
 were significantly decreased (Figure 5a and Fig. S7d). Consistent 
with the ratio of the most relevant 2GSH/GSSG redox couple, the expression of genes 
and proteins related to glutathione metabolism were highly increased, corresponding 
to significantly elevated levels of the potent cellular antioxidant GSH (Figure 5a and 
b, Fig. S7d and e).  
In summary, these data indicate a metabolic switch that leads amongst others to an 
increased pool of reduced glutathione. Clearly, the GSH concentration can vary a lot 
between different cells, depending on stress exposure and function 
48
. 
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To explore thermodynamic aspects of the cellular state, we next analysed the redox 
environment of NHEKs treated with RSV. Therefor, we considered intracellular 
concentrations of above-mentioned key metabolites, using the equation 18 (Eq. 18) 
48
.
 
                  ∑    [               ] 
 (      }
   
 
Eq. 18 
Indeed, via activation of the canonical Nrf2 pathway RSV treatment at hormetic 
concentrations increased in particular the level of endogenously produced GSH. This 
effect resulted in a shift of the cellular redox environment to a more reduced state 
(Figure 5c and for calculation-relevant parameters see Table S4) 
49
. Based on the 
2GSH/GSSG couple, which provides the most relevant cellular pool of reducing 
equivalents 
48
, we calculated a slight shift of redox environment of -2.61 mV mmol 
GSH per gram protein. A similar trend was observed by taking into account further 
redox couples (see also Fig. S7f and Table S4). According to our results, RSV 
treatment can contribute to an overall reduction of biological molecules containing for 
example thiol groups, as evident from the increased cellular GSH concentration 
(Figure 5a). In summary, the often-observed pleiotropic effects of RSV can finally be 
subsumed by the redox environment equation (Eq. 18) to explain and quantify a major 
(thermodynamic) state of the cellular system. In the ideal case the redox environment 
of the cell can be calculated by making use of the full “redoxome” and not only 
selected metabolite data, which might become possible in the future. Furthermore, 
exact knowledge of the concentrations of the various (reductive) metabolites such as 
GSH could be used to generate kinetic molecular networks of the cell. 
We then analysed if the observed reduced redox environment could potentially protect 
the cell from (oxidative) stress. Therefore, we subjected NHEKs to 16 hours pre-
treatment with 50 µM RSV. After replacement of medium the NHEK cells were 
devoid of any residual RSV. We then treated NHEKs with ~0.8% ethanol and 
analysed the endogenous generation of intracellular ROS from cellular metabolisation 
of ethanol, i.e. the level of oxidative stress (Figure 5d) 
24
. Notably, we observed that 
overall reduced cellular environment (owing to the observed increased pool of 
endogenous GSH) enabled RSV-pre-treated NHEKs to buffer the additional 
production of ROS due to biotransformation of ethanol (Figure 5d). The protective 
effects of pre-treatment with RSV were revised in a concentration-dependent manner 
by addition of 4-hydroxy-2-nonenal (HNE), an α,β-unsaturated aldehyde, which 
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mainly acts as a strong electrophile by depleting cellular sulfhydryl compounds like 
GSH (Figure 5d) and which might also interact with Nrf2 
28,50,51
.  
CONCLUSION 
Summarizing, we propose a bi-phasic pharmacological model for RSV, which might 
be extended to other pro-oxidative polyphenols. This model comprises i) generation 
of oxidation products at non-toxic concentrations in physiologically relevant sodium 
bicarbonate-containing media, ii) specific mediation of cellular response to oxidation 
induced by RSV by the redox-sensitive transcription factor Nrf2 and iii) induction of 
slight reductive shifting of cellular redox-environment to protect the cell from 
additional (oxidative) stress (Figure 6a and b).  
 
Figure 6: Molecular networks involved in RSV-induced cytoprotection against oxidative stress. (a) A dose-
dependent compound-target protein model is generally assumed to explain biological effects of RSV. Our 
proposed model integrates mechanism of action of RSV via production of ROS in physiologically relevant media, 
Nrf2-mediated cellular response and mild beneficial (hormetic) biological effects at normally applied 
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concentrations. Estrogen R = estrogen receptor, SIRT1 = silent mating type information regulation 2 homolog 1, 
PDE4 = phosphodiesterase 4. (b) At low concentrations oxidizing RSV induces mild stress, resulting in a 
metabolic and redox environment shift to increase the level of endogenous quenchers to eventually protect the cell 
from environmental stress. 
 
Clearly, the here proposed model largely depends on the pro- and anti-oxidative 
properties of RSV in a given microenvironment. We argue that bicarbonate 
containing media are essential for living systems (from simple micro- to higher 
mammalian organisms), and thus it seems that our model based on the pro-oxidative 
features of RSV might be extendable to a large variety of biological phenomena. 
Given that the here shown chemical properties of RSV appear dominant, we assume 
that not only mammalian but also microbial enzymatic conversion of RSV is probably 
less relevant than previously anticipated, which has to be explored in more detail in 
the future. Our data indicate that proper analysis of the potential pro- and anti-
oxidative features of RSV in a specific experimental set-up shall be thoroughly 
explored prior any biological investigation to define a common basis and thereby 
avoid any potential misinterpretation. 
In particular the human epidermis being predominantly prone to external stress might 
benefit from dermatological application of RSV. The here elaborated pro-oxidative 
features of RSV and the redox-environment shifting concept can fully explain such 
recent claims 
43
. Of note, whereas RSV might remain stable under low pH conditions 
in the stomach (see Figure 1 and 2 in Reference 
31
), physiologically well-known 
neutralization in the duodenum – by high concentrations of bicarbonate derived from 
the pancreas – might induce so far largely unexplored pro-oxidative features of RSV 
in the intestine.  
Considering the increase of endogenously produced GSH and reduction of the cellular 
redox environment as the main phenomena, the often-reported weak and pleiotropic 
effects of RSV on biological cells can be described quantitatively and in a 
comprehensive manner. On the other hand, in particular the effects derived from 
oxidation products with short lifetimes such as ROS are difficult to trace in vitro and 
in particular in vivo. This drawback might provoke scepticism how such “dirty” 
chemicals shall exert well-controllable cellular and physiological effects.  
Nevertheless, taking a systems view we suggest to apply the here explored paradigm 
for mathematically analysing the emerging relevant biological effects of pro-oxidative 
compounds such as RSV. For example, the determination of the redox environment 
allows for calculating the oxidation-buffering capacity of targeted cells under 
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investigation. Using such a thermodynamic framework and establishing kinetic 
networks, might be helpful approaches to rationally exploit the here observed 
beneficial bi-phasic effects of pro-oxidative compounds for therapeutic and 
preventive application, including development of chemical derivatives of RSV and 
molecular carriers to efficiently guide pro-oxidative molecules to the target tissues of 
choice. 
In general, hormetic induction of cellular fitness by pro-oxidative polyphenols such as 
RSV might represent a powerful approach to protect cells against physiological stress 
and to inhibit age-related diseases.  
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HIGHLIGHTS 
 RSV generates oxidation products under physiologically relevant conditions 
 Oxidation products of RSV are causative for an increased cell viability 
 Cellular response to RSV treatment primarily depends on activation of the redox-
sensitive transcription factor Nrf2  
 Nrf2 activation results in a concerted action of cellular defense pathways leading 
to increased concentrations of reducing equivalents 
 Oxidation of RSV results in a slight, “hormetic” shift of cellular redox-
environment thereby protecting cells against additional (oxidative) stress 
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